News Daily News More Excess Bleeding and No Benefit With Triple Therapy After PCI, Meta-analysis Finds Todd Neale May 05, 2017
News Conference News EAS 2017 Perceived Financial Barriers to Healthcare Worsen Cardiovascular Outcomes Even in Countries With Universal Medical Coverage Yael L. Maxwell April 27, 2017
News Daily News Choline, Common in Eggs and Liver, Raises TMAO Levels and Increases Platelet Aggregation Michael O'Riordan April 24, 2017
News Daily News If You Don’t Take Your Stroke Meds, This App Will Tell on You Todd Neale April 18, 2017
News Mortality and CVD Decline in Patients With Diabetes, but Biggest Strides Seen for Nonfatal Outcomes Michael O'Riordan April 13, 2017
News Daily News Apixaban Provides ‘Intermediate-Value’ Care, New Economic Analysis Shows Michael O'Riordan March 31, 2017
News Daily News Do NOACs Carry a Higher Risk of Acute MI? New Study Reopens Old Questions Todd Neale March 28, 2017
News Conference News ACC 2017 Many Patients Prescribed PCSK9 Inhibitors Never End Up Getting Them Yael L. Maxwell March 23, 2017
News Conference News ACC 2017 High-Dose Atorvastatin Does Not Impact Cognition, but Small Changes Observed on Brain MRI Michael O'Riordan March 21, 2017
News Conference News ACC 2017 Going to Low LDL Levels With Evolocumab Does Not Affect Memory, Brain Function: EBBINGHAUS Michael O'Riordan March 19, 2017
News Conference News ACC 2017 Replacing Aspirin With Low-Dose Rivaroxaban for Post-ACS Therapy Appears Safe Todd Neale March 18, 2017
News Conference News ACC 2017 ORION-1: Novel LDL-Lowering Treatment Could Reduce Costs, Increase Adherence Over PCSK9s Yael L. Maxwell March 17, 2017
News Conference News ACC 2017 SPIRE 1 and 2: Support for PCSK9 Inhibition but Not Bococizumab Yael L. Maxwell March 17, 2017
News Conference News ACC 2017 FOURIER: Evolocumab Reduces Risk of CVD Events by 15% Compared With Placebo Michael O'Riordan March 17, 2017
News Daily News Fish Oils: Yes for HF and Secondary Prevention, No for the General Population, Says AHA Michael O'Riordan March 15, 2017
News Daily News NOACs Seem to Perform Just Fine in Patients With A-fib and Most Types of Valvular Disease Todd Neale March 14, 2017
News Conference News ACC 2017 ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More Shelley Wood March 10, 2017
News Conference News ACC 2017 Does Hormone Replacement Therapy Curb Atherosclerosis? New Imaging Study Opens Old Questions Shelley Wood March 09, 2017
News Daily News Rising Subdural Hematoma Rates Appear to Be Linked to Greater Use of Antithrombotics Todd Neale March 03, 2017